The nation of Zimbabwe has rejected a significant American healthcare agreement valued at $367m (272 million pounds) spanning five years because of the United States' insistence on sensitive biological samples.
This move became public following a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".
A government spokesperson has since stated that the United States was requesting biological samples for research and profit but was not willing to share the benefits from any future treatments.
"We must now begin the difficult and regrettable process of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged continued dialogue to find a deal agreeable to both sides so the country's vital HIV treatment initiative can continue.
Broader Implications
This rejection comes after a similar case in Kenya, where a court suspended a similar deal with the US after legal challenges were filed about the security of citizens' health data.
After resuming the presidency recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had overseen aid for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government deals to enhance openness and accountability.
According to statements, Sixteen African countries have to date signed similar health pacts, constituting over $18.3bn in new funding.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to surrender its genetic material and health information indefinitely, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.
"Effectively, our country would provide the basic resources for medical research without any assurance that the resulting innovations would be accessible to our citizens should a future disease outbreak arise."
Sovereignty and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining structures previously set up through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to manage potential pandemics.
"This system is intended to guarantee that when a nation contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
These objections over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome ongoing dialogue with our American counterparts on how future collaboration could be structured in a manner that respects the independence and interests of each country."
Medical Community Reaction
Medical experts expressed it acknowledged the government's concerns, but suggested that negotiations should continue given that much of the nation's HIV programmes relied on international support.
"Where specific concerns arise, such as those involving data governance or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," the group commented.
The halted deal underscores the continuing challenges between accepting crucial foreign assistance and protecting a country's data in an ever more data-driven world.